Premalignant skin lesions
Therapeutic procedures · Group T8 — Surgical operations
| Benefit | Amount | Gap to fee |
|---|---|---|
| 85% | $40.25 | $7.05 |
| 75% | $35.50 | $11.80 |
Benefit amounts as published in the schedule, not recalculated.
Fee current from 1 Jul 2026.
(Anaes.) — anaesthesia may be claimed separately in association with this item.
Item 30192 requires 10 OR MORE premalignant lesions treated by ablative technique at that service. Treating fewer than 10 solar keratoses by cryotherapy attracts benefits on an attendance basis only - there is no procedure item, and billing 30192 for 3 or 4 lesions is a recovery. Seborrheic keratoses are attendance-basis regardless of number.
TN.8.9 Treatment of Keratoses, Warts etc (Items 30187, 30189, 30192 and 36815)
Treatment of seborrheic keratoses by any means, attracts benefits on an attendance basis only.
Treatment of fewer than 10 solar keratoses by ablative techniques such as cryotherapy attracts benefits on an attendance basis only. Where 10 or more solar keratoses are treated by ablative techniques, benefits are payable under item 30192.
Warts and molluscum contagiosum where treated by any means attract benefits on an attendance basis except where:
(a) admission for treatment in an operating theatre of an accredited day surgery facility or hospital is required. In this circumstance, benefits are paid under item 30189 where a definitive removal of the wart or molluscum contagiosum is to be undertaken.
(b) benefits have been paid under item 30189, and recurrence occurs.
(c) palmar and plantar warts are treated by laser and require treatment in an operating theatre of an accredited day surgery facility or hospital. In this circumstance, benefits are paid under item 30187.
| Item number | 30192 |
|---|---|
| Category | 3 — Therapeutic procedures |
| Group | T8 — Surgical operations |
| Subheading | — |
| Item type | S |
| Fee type | N |
| In schedule since | 1 Dec 1991 |
| Fee current from | 1 Jul 2026 |
| GP scope | Yes · tier 1 |